These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 18690870

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gastroretentive carbidopa/levodopa, DM-1992, for the treatment of advanced Parkinson's disease.
    Verhagen Metman L, Stover N, Chen C, Cowles VE, Sweeney M.
    Mov Disord; 2015 Aug; 30(9):1222-8. PubMed ID: 25847690
    [Abstract] [Full Text] [Related]

  • 14. The effect of tolcapone on levodopa pharmacokinetics is independent of levodopa/carbidopa formulation.
    Jorga K, Fotteler B, Sedek G, Nielsen T, Aitken J.
    J Neurol; 1998 Apr; 245(4):223-30. PubMed ID: 9591224
    [Abstract] [Full Text] [Related]

  • 15. Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease.
    Hauser RA, Ellenbogen AL, Metman LV, Hsu A, O'Connell MJ, Modi NB, Yao HM, Kell SH, Gupta SK.
    Mov Disord; 2011 Oct; 26(12):2246-52. PubMed ID: 21755537
    [Abstract] [Full Text] [Related]

  • 16. Novel Levodopa Formulations for Parkinson's Disease.
    Freitas ME, Ruiz-Lopez M, Fox SH.
    CNS Drugs; 2016 Nov; 30(11):1079-1095. PubMed ID: 27743318
    [Abstract] [Full Text] [Related]

  • 17. Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa.
    Othman AA, Rosebraugh M, Chatamra K, Locke C, Dutta S.
    J Parkinsons Dis; 2017 Nov; 7(2):275-278. PubMed ID: 28211816
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics.
    LeWitt PA.
    Mov Disord; 2015 Jan; 30(1):64-72. PubMed ID: 25449210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.